Ortho Evra Side Effects

Severe side effects that have been linked to the use of Ortho Evra birth control patches include:

Blood Clots and Deep Vein Thrombosis:

Deep Vein Thrombosis or DVT, is a blood clot that can form in your legs or calves. The women using the birth control patch who developed deep vein thrombosis (DVT) symptoms, some have died as a result of life threatening complications. Other studies have illustrated that using the Ortho Evra birth control patch may cause a woman to develop deep vein thrombosis (DVT) symptoms independent of other blood clot risk factors. It can lead to a very serious and life threatening condition called pulmonary embolism

Pulmonary Embolism:

A pulmonary embolism is a sudden blockage in a lung artery, usually due to a blood clot that traveled from the leg. This condition can cause permanent damage to part of your lung from lack of blood flow to lung tissue and damage to other organs in your body from not getting enough oxygen. The first reported death from Ortho Evra use was a pulmonary embolism.

Strokes and Heart Attacks:

The use of Ortho Evra has been directly linked with side effects such coughing blood, shortness of breath, sharp/crushing chest pains, heart attacks and strokes. Women who smoke put themselves at risk even more if they use this form of birth control.

Death:

Ortho Evra has been listed as the probable cause of at least 17 deaths due to pulmonary embolisms, strokes and heart attacks. To date, nearly 50 women have been seriously hurt by the birth control patch. There are, however, up to 4 million women still currently use the product world-wide, causing concern for officials who fear there will be more tragic consequences for those using the patch.

If you or a loved one have used the birth control patch, and have experienced any Ortho Evra side effects, including blood clots, heart attacks, strokes or even sudden death, contact us immediately. We will put you in touch with experienced Ortho Evra side effects attorneys that can help you with your case.